Nucleic acid binding, mitochondrial RNA binding Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4I8Z1
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 161 | 165 | PF00656 | 0.563 |
CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.420 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.331 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.650 |
DOC_CYCLIN_RxL_1 | 150 | 161 | PF00134 | 0.448 |
DOC_MAPK_DCC_7 | 291 | 299 | PF00069 | 0.345 |
DOC_MAPK_gen_1 | 176 | 185 | PF00069 | 0.403 |
DOC_MAPK_MEF2A_6 | 291 | 299 | PF00069 | 0.329 |
DOC_PP1_RVXF_1 | 32 | 39 | PF00149 | 0.513 |
DOC_PP2B_LxvP_1 | 83 | 86 | PF13499 | 0.369 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.614 |
DOC_WW_Pin1_4 | 170 | 175 | PF00397 | 0.730 |
DOC_WW_Pin1_4 | 249 | 254 | PF00397 | 0.432 |
DOC_WW_Pin1_4 | 299 | 304 | PF00397 | 0.442 |
LIG_14-3-3_CanoR_1 | 2 | 8 | PF00244 | 0.572 |
LIG_14-3-3_CanoR_1 | 93 | 101 | PF00244 | 0.352 |
LIG_BIR_III_2 | 190 | 194 | PF00653 | 0.343 |
LIG_BRCT_BRCA1_1 | 93 | 97 | PF00533 | 0.496 |
LIG_Clathr_ClatBox_1 | 215 | 219 | PF01394 | 0.380 |
LIG_eIF4E_1 | 251 | 257 | PF01652 | 0.343 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.628 |
LIG_FHA_1 | 250 | 256 | PF00498 | 0.408 |
LIG_FHA_1 | 304 | 310 | PF00498 | 0.644 |
LIG_FHA_2 | 224 | 230 | PF00498 | 0.577 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.485 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.439 |
LIG_LIR_Gen_1 | 177 | 185 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 196 | 200 | PF02991 | 0.279 |
LIG_LIR_Nem_3 | 245 | 249 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 35 | 41 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 43 | 48 | PF02991 | 0.307 |
LIG_PAM2_1 | 271 | 283 | PF00658 | 0.312 |
LIG_SH2_CRK | 45 | 49 | PF00017 | 0.354 |
LIG_SH2_SRC | 236 | 239 | PF00017 | 0.342 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 116 | 119 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 197 | 200 | PF00017 | 0.325 |
LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 251 | 254 | PF00017 | 0.476 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.386 |
LIG_SH3_3 | 128 | 134 | PF00018 | 0.348 |
LIG_SH3_3 | 168 | 174 | PF00018 | 0.752 |
LIG_SH3_3 | 21 | 27 | PF00018 | 0.458 |
LIG_SH3_5 | 193 | 197 | PF00018 | 0.345 |
LIG_SUMO_SIM_par_1 | 181 | 186 | PF11976 | 0.414 |
LIG_SUMO_SIM_par_1 | 214 | 219 | PF11976 | 0.337 |
LIG_WRC_WIRS_1 | 243 | 248 | PF05994 | 0.327 |
MOD_CDC14_SPxK_1 | 173 | 176 | PF00782 | 0.509 |
MOD_CDK_SPxK_1 | 170 | 176 | PF00069 | 0.515 |
MOD_CK1_1 | 264 | 270 | PF00069 | 0.403 |
MOD_CK1_1 | 289 | 295 | PF00069 | 0.359 |
MOD_CK1_1 | 302 | 308 | PF00069 | 0.541 |
MOD_CK2_1 | 175 | 181 | PF00069 | 0.499 |
MOD_CK2_1 | 223 | 229 | PF00069 | 0.372 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.428 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.436 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.331 |
MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.553 |
MOD_GlcNHglycan | 27 | 30 | PF01048 | 0.482 |
MOD_GlcNHglycan | 291 | 294 | PF01048 | 0.348 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.644 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.515 |
MOD_GSK3_1 | 299 | 306 | PF00069 | 0.560 |
MOD_GSK3_1 | 320 | 327 | PF00069 | 0.627 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.364 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.562 |
MOD_NEK2_1 | 286 | 291 | PF00069 | 0.296 |
MOD_NEK2_1 | 310 | 315 | PF00069 | 0.633 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.353 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.370 |
MOD_NEK2_2 | 3 | 8 | PF00069 | 0.625 |
MOD_NEK2_2 | 65 | 70 | PF00069 | 0.476 |
MOD_PIKK_1 | 223 | 229 | PF00454 | 0.552 |
MOD_PIKK_1 | 320 | 326 | PF00454 | 0.647 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.592 |
MOD_PKA_2 | 175 | 181 | PF00069 | 0.459 |
MOD_PKA_2 | 92 | 98 | PF00069 | 0.356 |
MOD_Plk_1 | 261 | 267 | PF00069 | 0.391 |
MOD_Plk_2-3 | 181 | 187 | PF00069 | 0.483 |
MOD_Plk_4 | 49 | 55 | PF00069 | 0.414 |
MOD_ProDKin_1 | 170 | 176 | PF00069 | 0.724 |
MOD_ProDKin_1 | 249 | 255 | PF00069 | 0.421 |
MOD_ProDKin_1 | 299 | 305 | PF00069 | 0.451 |
TRG_ENDOCYTIC_2 | 197 | 200 | PF00928 | 0.325 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.342 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5Y0 | Leptomonas seymouri | 33% | 77% |
A0A0N1PDA3 | Leptomonas seymouri | 77% | 100% |
A0A0S4INL4 | Bodo saltans | 38% | 76% |
A0A0S4JAJ5 | Bodo saltans | 62% | 100% |
A0A1X0NQR5 | Trypanosomatidae | 36% | 82% |
A0A1X0P2H5 | Trypanosomatidae | 69% | 100% |
A0A3Q8IH71 | Leishmania donovani | 33% | 76% |
A0A3R7M1X1 | Trypanosoma rangeli | 34% | 89% |
A0A3R7MCA7 | Trypanosoma rangeli | 69% | 100% |
A0A3S7X6N8 | Leishmania donovani | 100% | 100% |
A4H647 | Leishmania braziliensis | 33% | 100% |
A4HLI1 | Leishmania braziliensis | 92% | 100% |
A4HUG7 | Leishmania infantum | 33% | 100% |
D0A4Y9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 100% |
E9AN65 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
E9B3W0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
Q4Q464 | Leishmania major | 97% | 100% |
Q4QHG0 | Leishmania major | 33% | 100% |
V5B205 | Trypanosoma cruzi | 36% | 78% |
V5BLV5 | Trypanosoma cruzi | 69% | 100% |